These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 38593922)

  • 1. Anticoagulation in Patients with Premature Peripheral Artery Disease Undergoing Lower Extremity Revascularization.
    Kim TI; DeWan A; Murray M; Wang H; Mani A; Mena-Hurtado C; Guzman RJ; Ochoa Chaar CI
    Ann Vasc Surg; 2024 Aug; 105():150-157. PubMed ID: 38593922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lower Extremity Revascularization for Chronic Limb-Threatening Ischemia among Patients at the Extremes of Age.
    Kim TI; Aboian E; Fischer U; Zhang Y; Guzman RJ; Ochoa Chaar CI
    Ann Vasc Surg; 2021 Apr; 72():517-528. PubMed ID: 32927042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of bypass and endovascular interventions for advanced femoropopliteal disease in patients with premature peripheral artery disease.
    Kim TI; Zhang Y; Cardella JA; Guzman RJ; Ochoa Chaar CI
    J Vasc Surg; 2021 Dec; 74(6):1968-1977.e3. PubMed ID: 34090986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of dual antiplatelet therapy after lower extremity revascularization for chronic limb-threatening ischemia.
    Ramanan B; Jeon-Slaughter H; Chen X; Kashyap VS; Kirkwood ML; Timaran CH; Modrall JG; Tsai S
    J Vasc Surg; 2021 Oct; 74(4):1327-1334. PubMed ID: 34023428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Major Adverse Limb Events Among Patients with Premature Peripheral Artery Disease Compared with Those at the Common Age Undergoing Revascularization in the Vascular Quality Initiative.
    Kim TI; Loh S; DeWan A; Murray M; Mojibian H; Mani A; Mena-Hurtado C; Ochoa Chaar CI
    Ann Vasc Surg; 2022 Nov; 87():188-197. PubMed ID: 35926786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual antiplatelet therapy is associated with prolonged survival after lower extremity revascularization.
    Soden PA; Zettervall SL; Ultee KH; Landon BE; O'Malley AJ; Goodney PP; DeMartino RR; Arya S; Schermerhorn ML;
    J Vasc Surg; 2016 Dec; 64(6):1633-1644.e1. PubMed ID: 27575814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective Use of Anticoagulation or Dual Antiplatelet Therapy for Patients with Extra-anatomic Bypasses.
    Teveris V; Columbo J; Bartline P; Goodney P; Stone D; Suckow B
    Ann Vasc Surg; 2020 Jul; 66():272-281.e1. PubMed ID: 31931126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of open and endovascular lower extremity revascularization in active smokers with advanced peripheral arterial disease.
    Chen SL; Whealon MD; Kabutey NK; Kuo IJ; Sgroi MD; Fujitani RM
    J Vasc Surg; 2017 Jun; 65(6):1680-1689. PubMed ID: 28527930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative Outcomes of Peripheral Vascular Interventions in Patients on Chronic Anticoagulation with Factor Xa Inhibitors and Vitamin K Antagonists.
    Huttler JJ; Alameddine D; Damara FA; Rodriguez PP; Wu Z; Slade M; Strosberg D; Ochoa Chaar CI
    Ann Vasc Surg; 2024 Jul; 104():185-195. PubMed ID: 38493886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid increase in hybrid surgery for the treatment of peripheral artery disease in the Vascular Quality Initiative database.
    Fereydooni A; Zhou B; Xu Y; Deng Y; Dardik A; Ochoa Chaar CI
    J Vasc Surg; 2020 Sep; 72(3):977-986.e1. PubMed ID: 32067877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal medical management before lower extremity bypass for claudication in the veteran population.
    Williams CR; Jellison A; Martin L; Zhang C; Presson AP; Kraiss LW; Brooke BS
    J Vasc Surg; 2019 Feb; 69(2):545-554. PubMed ID: 30108008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Use and Impact of Cilostazol on Patients Undergoing Endovascular Peripheral Interventions.
    Alameddine D; Damara FA; Pinto Rodriguez P; Huttler J; Slade MD; Arhuidese I; Aboian E; Ochoa Chaar CI
    Ann Vasc Surg; 2024 Jun; 103():47-57. PubMed ID: 38387798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk Factors for Suboptimal Utilization of Statins and Antiplatelet Therapy in Patients Undergoing Revascularization for Symptomatic Peripheral Arterial Disease.
    Meltzer AJ; Sedrakyan A; Connolly PH; Ellozy S; Schneider DB;
    Ann Vasc Surg; 2018 Jan; 46():234-240. PubMed ID: 28602895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive factors for better bypass patency and limb salvage after prosthetic above-knee bypass reconstruction.
    Klingelhoefer E; Bergert H; Kersting S; Ludwig S; Weiss N; Schönleben F; Grützmann R; Gäbel G
    J Vasc Surg; 2016 Aug; 64(2):380-388.e1. PubMed ID: 27763266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of infrainguinal bypass determined by age in the Vascular Study Group of New England.
    Dermody M; Homsy C; Zhao Y; Goodney PP; Estes JM;
    J Vasc Surg; 2015 Jul; 62(1):83-92. PubMed ID: 25953015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statin use improves limb salvage after intervention for peripheral arterial disease.
    Parmar GM; Novak Z; Spangler E; Patterson M; Passman MA; Beck AW; Pearce BJ
    J Vasc Surg; 2019 Aug; 70(2):539-546. PubMed ID: 30718113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antithrombotic therapy and major adverse limb events in patients with chronic lower extremity arterial disease: systematic review and meta-analysis from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy in Collaboration with the European Society of Cardiology Working Group on Aorta and Peripheral Vascular Diseases.
    Savarese G; Reiner MF; Uijl A; D'Amario D; Agewall S; Atar D; Baumgartner I; Borghi C; De Carlo M; Drexel H; Kaski JC; Kjeldsen KP; Kucher N; Lund LH; Niessner A; Semb AG; Schmidt TA; Sulzgruber P; Tamargo J; Vitale C; Wassmann S; Aboyans V; Lewis BS
    Eur Heart J Cardiovasc Pharmacother; 2020 Apr; 6(2):86-93. PubMed ID: 31392312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticoagulation and antiplatelet medications do not affect aortic remodeling after thoracic endovascular aortic repair for type B aortic dissection.
    Chang H; Rockman CB; Cayne NS; Veith FJ; Jacobowitz GR; Siracuse JJ; Patel VI; Garg K
    J Vasc Surg; 2021 Dec; 74(6):1833-1842.e1. PubMed ID: 34182028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Following the COMPASS: Antithrombotic Prescription Trends in Patients with Symptomatic Peripheral Arterial Disease following Revascularization.
    Elzawy G; Chan J; Eisenberg N; Roche-Nagle G
    Ann Vasc Surg; 2024 Sep; 106():341-349. PubMed ID: 38851315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cilostazol and freedom from amputation after lower extremity revascularization.
    Neel JD; Kruse RL; Dombrovskiy VY; Vogel TR
    J Vasc Surg; 2015 Apr; 61(4):960-4. PubMed ID: 25595396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.